Theramex And Enzene Continue Alliance With Deal For RoActemra Rival

Companies Aim To Commercialize Tocilizumab In Europe, UK, Switzerland And Australia

2026
Theramex and Enzene plan to commercialize tocilizumab from 2026 • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products